Effect of Vitamin D on Everolimus Trough Concentrations Among Heart Transplanted Patients
NCT ID: NCT03403647
Last Updated: 2019-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2018-07-15
2019-04-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supplementation With Vitamin D to Patients With Heart Failure (D-Heart).
NCT03289637
Vitamin D and Inflammatory Cytokine Levels After Acute Myocardial Infraction (MI)
NCT01115842
VItamin D as a Novel Determinant of Injurious Cardiac Remodelling After acuTE Myocardial Infarction
NCT03086746
Myocardial Function and Vitamin D Supplementation in Diabetes.
NCT03437421
Efficacy Of Ergocalciferol In Adults According To BMI
NCT02435771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D deficient
Vitamin D supplementation and close everolimus trough levels monitoring with oral dose adjustments
Vitamin D
Oral daily vitamin D
No vitamin D deficiency
Regular and routine monitoring
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
Oral daily vitamin D
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheba Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.Itai Gueta
Physician in the institute for clinical pharmacology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sheba Medical Center
Ramat Gan, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Vitamin D and Everolimus
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.